Cervical Spondylosis of vertebral artery Type
Conditions
Interventions
experimental group:Sun Meridian Tendon Acupuncture Technique
control group:Oral flunarizine hydrochloride capsules
Sponsors
Gansu provincial hospital of traditional Chinese medicine
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the above diagnostic criteria; (2) Those who are between 30-65 years old, regardless of gender; (3) Those whose disease course is less than 1 year; (4) Those whose vertigo score in ESCV scale is 2-6 points ; (5) Those who can tolerate and agree to acupotomy treatment or receive flunarizine hydrochloride capsules treatment; (6) Those who can cooperate with examination, adhere to treatment, and cooperate with curative effect observation and complete follow-up; (7) Voluntarily sign the informed consent form And strictly abide by this researcher.
Exclusion criteria
Exclusion criteria: (1) Combined with cervical spondylosis of nerve root type, sympathetic nerve type, spinal type, and esophageal type; (2) Vertigo caused by otogenic, ophthalmic and other causes; (3) Vertebral artery and basilar artery caused by other diseases Abnormal hemodynamic changes; (4) patients with acute and chronic infection of neck skin; (5) patients with severe heart, liver, kidney, blood system, malignant tumor and other primary diseases; (6) pregnant women Or those who are allergic to flunarizine hydrochloride capsules; (7) Those who are intolerant or afraid of acupuncture treatment; (8) Those who have serious mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vertebral-basilar blood flow detection;Cervical Vertigo Symptoms and Function Assessment Scale; | — |
Countries
China
Contacts
Public ContactWang Haidong
Gansu provincial hospital of traditional Chinese medicine
Outcome results
None listed